This story was originally published in The Highlight. To get access to member-exclusive stories like this every month, become a Vox Member today. Every day it seems scientists are making breakthroughs in Alzheimer’s disease. New treatments that actually slow the disease’s progression — lecanemab and donanemab — have finally appeared on pharmacy shelves in the past few years, delivering […]